On February 2, 2024, the Judicial Panel on Multidistrict Litigation (JPML) ruled that all federal lawsuits involving Ozempic, Wegovy, Rybelsus, and similar medications be consolidated in the Eastern District of Pennsylvania for pre-trial proceedings. Since then, both sides have been working toward selecting a small…
The recent surge in popularity of Ozempic and other similar drugs—called GLP-1 inhibitors—has encouraged many people to take the medication for weight loss without incorporating recommended lifestyle changes like exercising and eating less. A recent study, however, warns against this approach. Scientists discovered that when…
On February 9, 2024, an Illinois woman filed a new Ozempic lawsuit in the U.S. District Court for the Northern District of Illinois. She claims that after taking the medication, she suffered from gastroparesis, also known as stomach paralysis. She seeks both compensatory and punitive…
On December 1, 2023, a group of plaintiffs filed a motion request with the U.S. Judicial Panel on Multidistrict Litigation (JPML) to consolidate all federally filed Ozempic, Wegovy, and Mounjaro lawsuits, alleging gastrointestinal and associated injuries. All of these products include medications called glucagon-like peptide-1…
The U.S. Food and Drug Administration (FDA) has been looking into the potential side effects of diabetes and weight-loss drugs Ozempic and Wegovy, including suicidal ideation. The administration noticed potential signals of the serious risk in the FDA Adverse Event Reporting System (FAERS), which contains…
In a significant development, the U.S. Food and Drug Administration (FDA) is poised to propose a ban on certain hair-straightening products, specifically those containing formaldehyde and other formaldehyde-releasing chemicals like methylene or glycol. These chemicals are common in various hair relaxers and pressing products and…
A Florida woman recently filed a new EzriCare eye drops lawsuit in the Circuit Court of the 11th Judicial Circuit in and for Miami-Dade County, Florida. She claims that after using the eye drops, she suffered catastrophic permanent injuries. She seeks compensation for her medical…
On January 20, 2023, the U.S. Centers for Disease Control & Prevention (CDC) warned about a potential link between EzriCare and other artificial eye drops and antibiotic-resistant infections. According to a recently released however, a woman came to the emergency room at the Cleveland Medical…
The U.S. Food and Drug Administration (FDA) recently announced the recall of two more brands of eye drops due to potential contamination with antibiotic-resistant bacteria. This latest recall comes only a few weeks after Global Pharma announced the recall of EzriCare and Delsam Pharma eye…
Horizon Pharmaceuticals—makers of thyroid eye disease medication Tepezza—recently filed a motion to dismiss a recent lawsuit filed by a plaintiff who claims the medication caused her to suffer from permanent hearing loss. The plaintiff stated in her complaint that she received Tepezza infusions to treat…
